THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 21 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 6,000,000 | $5,827,000 | 3.55% |
| DeepCurrents Investment Group LLC | 21,223,000 | $20,803,000 | 1.80% |
| ZAZOVE ASSOCIATES LLC | 19,230,000 | $18,725,000 | 1.77% |
| Mohican Financial Management, LLC | 500,000 | $494,000 | 1.61% |
| Castle Creek Arbitrage, LLC | 5,149,000 | $5,015,000 | 1.47% |
| LINDEN ADVISORS LP | 62,688,000 | $61,071,000 | 1.40% |
| Verition Fund Management LLC | 10,817,000 | $10,504,000 | 0.41% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,100,000 | $23,451,000 | 0.32% |
| Baupost Group | 30,000,000 | $29,213,000 | 0.24% |
| SSI INVESTMENT MANAGEMENT LLC | 2,763,000 | $2,676,000 | 0.22% |